Published in Antimicrob Agents Chemother on December 01, 2000
Riddle of biofilm resistance. Antimicrob Agents Chemother (2001) 7.19
Staphylococcal biofilms. Curr Top Microbiol Immunol (2008) 4.26
Bacterial adhesion: seen any good biofilms lately? Clin Microbiol Rev (2002) 3.62
Biofilms. Cold Spring Harb Perspect Biol (2010) 3.10
From clinical microbiology to infection pathogenesis: how daring to be different works for Staphylococcus lugdunensis. Clin Microbiol Rev (2008) 2.47
icaR encodes a transcriptional repressor involved in environmental regulation of ica operon expression and biofilm formation in Staphylococcus epidermidis. J Bacteriol (2002) 2.43
The transition metal gallium disrupts Pseudomonas aeruginosa iron metabolism and has antimicrobial and antibiofilm activity. J Clin Invest (2007) 2.26
Association between methicillin susceptibility and biofilm regulation in Staphylococcus aureus isolates from device-related infections. J Clin Microbiol (2007) 1.89
The teicoplanin-associated locus regulator (TcaR) and the intercellular adhesin locus regulator (IcaR) are transcriptional inhibitors of the ica locus in Staphylococcus aureus. J Bacteriol (2004) 1.81
Evidence for icaADBC-independent biofilm development mechanism in methicillin-resistant Staphylococcus aureus clinical isolates. J Clin Microbiol (2005) 1.79
The bacterial insertion sequence element IS256 occurs preferentially in nosocomial Staphylococcus epidermidis isolates: association with biofilm formation and resistance to aminoglycosides. Infect Immun (2004) 1.74
Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces. Antimicrob Agents Chemother (2003) 1.69
RsbU-dependent regulation of Staphylococcus epidermidis biofilm formation is mediated via the alternative sigma factor sigmaB by repression of the negative regulator gene icaR. Infect Immun (2004) 1.57
Antibiotics as signal molecules. Chem Rev (2011) 1.54
Gentamicin promotes Staphylococcus aureus biofilms on silk suture. J Surg Res (2011) 1.53
Inhibition of staphylococcal biofilm formation by nitrite. J Bacteriol (2007) 1.51
Extracellular carbohydrate-containing polymers of a model biofilm-producing strain, Staphylococcus epidermidis RP62A. Infect Immun (2005) 1.50
Global transcriptome analysis of Staphylococcus aureus response to hydrogen peroxide. J Bacteriol (2006) 1.49
Inactivations of rsbU and sarA by IS256 represent novel mechanisms of biofilm phenotypic variation in Staphylococcus epidermidis. J Bacteriol (2004) 1.47
Glucose-related dissociation between icaADBC transcription and biofilm expression by Staphylococcus epidermidis: evidence for an additional factor required for polysaccharide intercellular adhesin synthesis. J Bacteriol (2003) 1.47
Staphylococcus epidermidis polysaccharide intercellular adhesin production significantly increases during tricarboxylic acid cycle stress. J Bacteriol (2005) 1.44
In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates. Antimicrob Agents Chemother (2006) 1.37
Relevant role of fibronectin-binding proteins in Staphylococcus aureus biofilm-associated foreign-body infections. Infect Immun (2009) 1.32
Biofilm formation by clinical isolates and the implications in chronic infections. BMC Infect Dis (2013) 1.30
Biofilm formation and the presence of the intercellular adhesion locus ica among staphylococci from food and food processing environments. Appl Environ Microbiol (2003) 1.29
Effect of cinnamon oil on icaA expression and biofilm formation by Staphylococcus epidermidis. Appl Environ Microbiol (2009) 1.19
Tricarboxylic acid cycle-dependent regulation of Staphylococcus epidermidis polysaccharide intercellular adhesin synthesis. J Bacteriol (2008) 1.17
Susceptibility of Pseudomonas aeruginosa Biofilm to Alpha-Helical Peptides: D-enantiomer of LL-37. Front Microbiol (2011) 1.14
Analysis of bacterial biofilms using NMR-based metabolomics. Future Med Chem (2012) 1.11
Antibiotic Resistance Related to Biofilm Formation in Klebsiella pneumoniae. Pathogens (2014) 1.10
Enhancement of biofilm formation by subinhibitory concentrations of macrolides in icaADBC-positive and -negative clinical isolates of Staphylococcus epidermidis. Antimicrob Agents Chemother (2010) 1.06
Furanone at subinhibitory concentrations enhances staphylococcal biofilm formation by luxS repression. Antimicrob Agents Chemother (2009) 1.06
Extracellular DNA-dependent biofilm formation by Staphylococcus epidermidis RP62A in response to subminimal inhibitory concentrations of antibiotics. Res Microbiol (2011) 1.06
Effects of growth in the presence of subinhibitory concentrations of dicloxacillin on Staphylococcus epidermidis and Staphylococcus haemolyticus biofilms. Appl Environ Microbiol (2005) 1.05
Influence of tigecycline on expression of virulence factors in biofilm-associated cells of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2009) 1.04
In situ rheology of Staphylococcus epidermidis bacterial biofilms. Soft Matter (2013) 1.04
Recombinant human DNase I decreases biofilm and increases antimicrobial susceptibility in staphylococci. J Antibiot (Tokyo) (2011) 1.03
Planktonic aggregates of Staphylococcus aureus protect against common antibiotics. PLoS One (2012) 1.02
Reduced vancomycin susceptibility in an in vitro catheter-related biofilm model correlates with poor therapeutic outcomes in experimental endocarditis due to methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2013) 1.02
Establishment of an arbitrary PCR for rapid identification of Tn917 insertion sites in Staphylococcus epidermidis: characterization of biofilm-negative and nonmucoid mutants. Appl Environ Microbiol (2003) 1.02
Antibiotic susceptibility of coagulase-negative staphylococci isolated from very low birth weight babies: comprehensive comparisons of bacteria at different stages of biofilm formation. Ann Clin Microbiol Antimicrob (2010) 1.01
NMR analysis of a stress response metabolic signaling network. J Proteome Res (2011) 1.00
Genetic regulation of the intercellular adhesion locus in staphylococci. Front Cell Infect Microbiol (2012) 0.97
Activity of gallidermin on Staphylococcus aureus and Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother (2012) 0.96
The relationship between inhibition of bacterial adhesion to a solid surface by sub-MICs of antibiotics and subsequent development of a biofilm. Res Microbiol (2005) 0.95
Static biofilm cultures of Gram-positive pathogens grown in a microtiter format used for anti-biofilm drug discovery. Curr Protoc Pharmacol (2010) 0.93
AI-2/LuxS is involved in increased biofilm formation by Streptococcus intermedius in the presence of antibiotics. Antimicrob Agents Chemother (2009) 0.93
Identification of the sigB operon in Staphylococcus epidermidis: construction and characterization of a sigB deletion mutant. Infect Immun (2001) 0.92
Involvement of iron in biofilm formation by Staphylococcus aureus. PLoS One (2012) 0.89
Bacterial Extracellular Polysaccharides in Biofilm Formation and Function. Microbiol Spectr (2015) 0.89
Influence of iron and aeration on Staphylococcus aureus growth, metabolism, and transcription. J Bacteriol (2014) 0.88
Biofilm: the microbial "bunker" for intravascular catheter-related infection. Support Care Cancer (2004) 0.86
Genetic determinants and biofilm formation of clinical Staphylococcus epidermidis isolates from blood cultures and indwelling devises. Eur J Microbiol Immunol (Bp) (2013) 0.85
Depression of biofilm formation and antibiotic resistance by sarA disruption in Staphylococcus epidermidis. World J Gastroenterol (2006) 0.84
Structure and function of Pseudomonas aeruginosa protein PA1324 (21-170). Protein Sci (2009) 0.84
Tetracycline and chloramphenicol efficiency against selected biofilm forming bacteria. Curr Microbiol (2009) 0.84
mecA is not involved in the sigmaB-dependent switch of the expression phenotype of methicillin resistance in Staphylococcus epidermidis. Antimicrob Agents Chemother (2005) 0.83
Beta- lactam antibiotics stimulate biofilm formation in non-typeable haemophilus influenzae by up-regulating carbohydrate metabolism. PLoS One (2014) 0.83
Microarray analysis of toxicogenomic effects of ortho-phenylphenol in Staphylococcus aureus. BMC Genomics (2008) 0.83
In vitro biofilm forming potential of Streptococcus suis isolated from human and swine in China. Braz J Microbiol (2012) 0.82
Subinhibitory concentrations of triclosan promote Streptococcus mutans biofilm formation and adherence to oral epithelial cells. PLoS One (2014) 0.82
Effect of subinhibitory concentrations of fluoroquinolones on biofilm production by clinical isolates of Streptococcus pyogenes. Indian J Med Res (2013) 0.82
Sub-MIC Tylosin Inhibits Streptococcus suis Biofilm Formation and Results in Differential Protein Expression. Front Microbiol (2016) 0.81
Role of environmental and antibiotic stress on Staphylococcus epidermidis biofilm microstructure. Langmuir (2013) 0.81
Methods to identify enzymes that degrade the main extracellular polysaccharide component of Staphylococcus epidermidis biofilms. Virulence (2013) 0.80
Antibiotic susceptibility of Aggregatibacter actinomycetemcomitans JP2 in a biofilm. J Oral Microbiol (2013) 0.79
Halogenated indoles eradicate bacterial persister cells and biofilms. AMB Express (2016) 0.78
Role of PBPD1 in stimulation of Listeria monocytogenes biofilm formation by subminimal inhibitory β-lactam concentrations. Antimicrob Agents Chemother (2014) 0.78
Increased temperature enhances the antimicrobial effects of daptomycin, vancomycin, tigecycline, fosfomycin, and cefamandole on staphylococcal biofilms. Antimicrob Agents Chemother (2010) 0.77
Beyond conventional antibiotics - New directions for combination products to combat biofilm. Adv Drug Deliv Rev (2016) 0.77
Oxygen-mediated regulation of biofilm development is controlled by the alternative sigma factor sigma(B) in Staphylococcus epidermidis. Appl Environ Microbiol (2008) 0.76
Effects of Subinhibitory Concentrations of Ceftaroline on Methicillin-Resistant Staphylococcus aureus (MRSA) Biofilms. PLoS One (2016) 0.76
Antibacterial and Antibiofilm Effect of Low Viscosity Chitosan against Staphylococcus epidermidis. Int J Microbiol (2016) 0.75
Biofilm formation on biotic and abiotic surfaces in the presence of antimicrobials by Escherichia coli Isolates from cases of bovine mastitis. Appl Environ Microbiol (2014) 0.75
AiiA quorum-sensing quenching controls proteolytic activity and biofilm formation by Enterobacter cloacae. Curr Microbiol (2012) 0.75
Evolution of antimicrobial peptides to self-assembled peptides for biomaterial applications. Pathogens (2014) 0.75
Staphylococcus aureus Aggregation and Coagulation Mechanisms, and Their Function in Host-Pathogen Interactions. Adv Appl Microbiol (2016) 0.75
Natural-Product Antibiotics: Cues for Modulating Bacterial Biofilm Formation. Trends Microbiol (2017) 0.75
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res (1979) 214.95
Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene (1985) 213.67
Bacterial biofilms: a common cause of persistent infections. Science (1999) 40.82
Microbial biofilms. Annu Rev Microbiol (1995) 21.58
The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science (1998) 19.92
The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage. Nature (1983) 19.44
Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol (1985) 10.22
The intercellular adhesion (ica) locus is present in Staphylococcus aureus and is required for biofilm formation. Infect Immun (1999) 7.22
Molecular basis of intercellular adhesion in the biofilm-forming Staphylococcus epidermidis. Mol Microbiol (1996) 7.16
Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin Microbiol Rev (1997) 6.98
Improved method for electroporation of Staphylococcus aureus. FEMS Microbiol Lett (1992) 6.18
Thinking about bacterial populations as multicellular organisms. Annu Rev Microbiol (1998) 5.92
Growth characteristics of group A streptococci in a new chemically defined medium. Infect Immun (1980) 5.90
The intercellular adhesin involved in biofilm accumulation of Staphylococcus epidermidis is a linear beta-1,6-linked glucosaminoglycan: purification and structural analysis. J Bacteriol (1996) 5.82
Update on clinical significance of coagulase-negative staphylococci. Clin Microbiol Rev (1994) 5.77
Gene replacement in Staphylococcus carnosus and Staphylococcus xylosus. FEMS Microbiol Lett (1997) 5.02
A method to isolate RNA from gram-positive bacteria and mycobacteria. Anal Biochem (1994) 4.24
Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen. Science (1999) 4.08
Coagulase-negative staphylococci: pathogens associated with medical progress. Clin Infect Dis (1994) 3.88
Characterization of the N-acetylglucosaminyltransferase activity involved in the biosynthesis of the Staphylococcus epidermidis polysaccharide intercellular adhesin. J Biol Chem (1998) 3.80
Detection of the intercellular adhesion gene cluster (ica) and phase variation in Staphylococcus epidermidis blood culture strains and mucosal isolates. Infect Immun (1997) 3.71
A novel mechanism of phase variation of virulence in Staphylococcus epidermidis: evidence for control of the polysaccharide intercellular adhesin synthesis by alternating insertion and excision of the insertion sequence element IS256. Mol Microbiol (1999) 3.48
Transformation of Staphylococcus epidermidis and other staphylococcal species with plasmid DNA by electroporation. FEMS Microbiol Lett (1990) 3.45
The ica locus of Staphylococcus epidermidis encodes production of the capsular polysaccharide/adhesin. Infect Immun (1998) 3.44
Antibiotic resistance in gram-positive bacteria: epidemiological aspects. J Antimicrob Chemother (1999) 2.10
PCR-Based assay for discrimination between invasive and contaminating Staphylococcus epidermidis strains. J Clin Microbiol (2000) 2.05
Staphylococcus epidermidis: emerging resistance and need for alternative agents. Clin Infect Dis (1998) 1.83
Association of biofilm production of coagulase-negative staphylococci with expression of a specific polysaccharide intercellular adhesin. J Infect Dis (1996) 1.72
Increased expression of fibronectin-binding proteins by fluoroquinolone-resistant Staphylococcus aureus exposed to subinhibitory levels of ciprofloxacin. Antimicrob Agents Chemother (1997) 1.71
Effects of subinhibitory concentrations of antibiotics on alpha-toxin (hla) gene expression of methicillin-sensitive and methicillin-resistant Staphylococcus aureus isolates. Antimicrob Agents Chemother (1998) 1.70
Analysis of expression of the alpha-toxin gene (hla) of Staphylococcus aureus by using a chromosomally encoded hla::lacZ gene fusion. Infect Immun (1997) 1.61
Antibiotics and prevention of microbial colonization of catheters. Antimicrob Agents Chemother (1995) 1.57
Staphylococcus carnosus: a new host organism for gene cloning and protein production. Soc Appl Bacteriol Symp Ser (1990) 1.54
Inhibition of protein synthesis by streptogramins and related antibiotics. J Antimicrob Chemother (1997) 1.54
The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium. Synercid Emergency-Use Study Group. J Antimicrob Chemother (1999) 1.39
Impact of bacterial biofilm formation on in vitro and in vivo activities of antibiotics. Antimicrob Agents Chemother (1998) 1.27
Lack of mecA transcription in slime-negative phase variants of methicillin-resistant Staphylococcus epidermidis. Antimicrob Agents Chemother (1994) 1.21
The effects of adherence to silicone surfaces on antibiotic susceptibility in Staphylococcus aureus. Microbiology (1997) 1.20
Chromosomal rearrangements affecting biofilm production and antibiotic resistance in a Staphylococcus epidermidis strain causing shunt-associated ventriculitis. Int J Med Microbiol (2000) 1.19
Antibiotics and the expression of staphylococcal virulence. J Antimicrob Chemother (1995) 1.14
In-vitro and in-vivo antibacterial activity of quinupristin/dalfopristin. J Antimicrob Chemother (1997) 1.11
Effect of subinhibitory concentrations of vancomycin, cefazolin, ofloxacin, L-ofloxacin and D-ofloxacin on adherence to intravascular catheters and biofilm formation by Staphylococcus epidermidis. J Antimicrob Chemother (1998) 1.09
The pharmacokinetics of quinupristin/dalfopristin in laboratory animals and in humans. J Antimicrob Chemother (1997) 1.08
Treatment of hospitalized patients with complicated gram-positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin. Synercid Skin and Skin Structure Infection Group. J Antimicrob Chemother (1999) 0.97
Induction of Staphylococcus epidermidis biofilm formation by environmental factors: the possible involvement of the alternative transcription factor sigB. Adv Exp Med Biol (2000) 0.93
Medical relevance of low concentrations of antibiotics. J Antimicrob Chemother (1993) 0.89
Activity of quinupristin/dalfopristin against Staphylococcus epidermidis in biofilms: a comparison with ciprofloxacin. J Antimicrob Chemother (1997) 0.89
Activity of quinupristin/dalfopristin against gram-positive bacteria: clinical applications and therapeutic potential. J Antimicrob Chemother (1997) 0.88
Effects of low, subinhibitory concentrations of antibiotics on expression of a virulence gene cluster of pathogenic Escherichia coli by using a wild-type gene fusion. Int J Antimicrob Agents (1993) 0.87
Subinhibitory concentrations of antibiotics affect cell surface properties of Streptococcus sobrinus. J Bacteriol (1995) 0.87
In-vitro bactericidal activity of quinupristin/dalfopristin against adherent Staphylococcus aureus. J Antimicrob Chemother (1997) 0.79
Identifying predictors of high quality care in English general practice: observational study. BMJ (2001) 9.34
Excision of large DNA regions termed pathogenicity islands from tRNA-specific loci in the chromosome of an Escherichia coli wild-type pathogen. Infect Immun (1994) 5.56
Assessment of resolution and intercenter reproducibility of results of genotyping Staphylococcus aureus by pulsed-field gel electrophoresis of SmaI macrorestriction fragments: a multicenter study. J Clin Microbiol (1998) 5.38
Typing of Staphylococcus aureus by pulsed-field gel electrophoresis, zymotyping, capsular typing, and phage typing: resolution of clonal relationships. J Clin Microbiol (1993) 4.36
A single clone of Staphylococcus aureus causes the majority of cases of toxic shock syndrome. Proc Natl Acad Sci U S A (1990) 3.76
Detection of the intercellular adhesion gene cluster (ica) and phase variation in Staphylococcus epidermidis blood culture strains and mucosal isolates. Infect Immun (1997) 3.71
Cloning and characterization of genes involved in production of mannose-resistant, neuraminidase-susceptible (X) fimbriae from a uropathogenic O6:K15:H31 Escherichia coli strain. Infect Immun (1985) 3.58
A novel mechanism of phase variation of virulence in Staphylococcus epidermidis: evidence for control of the polysaccharide intercellular adhesin synthesis by alternating insertion and excision of the insertion sequence element IS256. Mol Microbiol (1999) 3.48
Emergence of heterogeneous intermediate vancomycin resistance in Staphylococcus aureus isolates in the Düsseldorf area. J Antimicrob Chemother (1999) 3.42
Cloning of the chromosomal determinants encoding hemolysin production and mannose-resistant hemagglutination in Escherichia coli. J Bacteriol (1982) 3.28
Dynamic, mitotic-like behavior of a bacterial protein required for accurate chromosome partitioning. Genes Dev (1997) 3.28
Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. Euro Surveill (2010) 3.15
Assignment of Staphylococcus isolates to groups by spa typing, SmaI macrorestriction analysis, and multilocus sequence typing. J Clin Microbiol (2006) 3.15
vanA-mediated high-level glycopeptide resistance in Enterococcus faecium from animal husbandry. FEMS Microbiol Lett (1995) 3.00
Isolation and characterization of the alpha-sialyl-beta-2,3-galactosyl-specific adhesin from fimbriated Escherichia coli. Proc Natl Acad Sci U S A (1987) 2.91
High interlaboratory reproducibility of DNA sequence-based typing of bacteria in a multicenter study. J Clin Microbiol (2006) 2.80
Emergence and spread of vancomycin resistance among enterococci in Europe. Euro Surveill (2008) 2.78
Alternative transcription factor sigma(B) is involved in regulation of biofilm expression in a Staphylococcus aureus mucosal isolate. J Bacteriol (2000) 2.78
Enterococcus faecium strains with vanA-mediated high-level glycopeptide resistance isolated from animal foodstuffs and fecal samples of humans in the community. Microb Drug Resist (1995) 2.75
Large, unstable inserts in the chromosome affect virulence properties of uropathogenic Escherichia coli O6 strain 536. J Bacteriol (1986) 2.65
Regulation of sigmaB-dependent transcription of sigB and asp23 in two different Staphylococcus aureus strains. Mol Gen Genet (1999) 2.62
Spontaneous deletions and flanking regions of the chromosomally inherited hemolysin determinant of an Escherichia coli O6 strain. J Bacteriol (1983) 2.61
Cloned hemolysin genes from Escherichia coli that cause urinary tract infection determine different levels of toxicity in mice. Infect Immun (1983) 2.60
Resuscitation of viable but nonculturable Legionella pneumophila Philadelphia JR32 by Acanthamoeba castellanii. Appl Environ Microbiol (1997) 2.45
Multicenter evaluation of epidemiological typing of methicillin-resistant Staphylococcus aureus strains by repetitive-element PCR analysis. The European Study Group on Epidemiological Markers of the ESCMID. J Clin Microbiol (2000) 2.28
Hemolysin production as a virulence marker in symptomatic and asymptomatic urinary tract infections caused by Escherichia coli. Infect Immun (1983) 2.26
Gene clusters encoding the cytotoxic necrotizing factor type 1, Prs-fimbriae and alpha-hemolysin form the pathogenicity island II of the uropathogenic Escherichia coli strain J96. FEMS Microbiol Lett (1995) 2.25
spa Typing of Staphylococcus aureus as a frontline tool in epidemiological typing. J Clin Microbiol (2007) 2.24
Clonal distribution of superantigen genes in clinical Staphylococcus aureus isolates. J Clin Microbiol (2007) 2.17
Regulation of the Shiga-like toxin II operon in Escherichia coli. Infect Immun (1996) 2.13
Clonal dissemination of epidemic methicillin-resistant Staphylococcus aureus in Belgium and neighboring countries. Clin Microbiol Infect (2000) 2.11
Prevalence and molecular characteristics of methicillin-resistant Staphylococcus aureus (MRSA) among pigs on German farms and import of livestock-related MRSA into hospitals. Eur J Clin Microbiol Infect Dis (2009) 2.04
Virulence patterns and long-range genetic mapping of extraintestinal Escherichia coli K1, K5, and K100 isolates: use of pulsed-field gel electrophoresis. Infect Immun (1991) 2.02
Characterization of the sigma(B) regulon in Staphylococcus aureus. J Bacteriol (2000) 2.00
Environmental strains of Enterococcus faecium with inducible high-level resistance to glycopeptides. FEMS Microbiol Lett (1993) 1.98
Laboratory tools and strategies for methicillin-resistant Staphylococcus aureus screening, surveillance and typing: state of the art and unmet needs. Clin Microbiol Infect (2009) 1.95
Quality assessment for three common conditions in primary care: validity and reliability of review criteria developed by expert panels for angina, asthma and type 2 diabetes. Qual Saf Health Care (2002) 1.89
Pulsed field electrophoresis of genomic restriction fragments for the detection of nosocomial Legionella pneumophila in hospital water supplies. J Clin Microbiol (1991) 1.89
S-Fimbria-encoding determinant sfa(I) is located on pathogenicity island III(536) of uropathogenic Escherichia coli strain 536. Infect Immun (2001) 1.89
Decreased incidence of VanA-type vancomycin-resistant enterococci isolated from poultry meat and from fecal samples of humans in the community after discontinuation of avoparcin usage in animal husbandry. Microb Drug Resist (1999) 1.88
Multiple copies of hemolysin genes and associated sequences in the chromosomes of uropathogenic Escherichia coli strains. J Bacteriol (1984) 1.87
A genomic island, termed high-pathogenicity island, is present in certain non-O157 Shiga toxin-producing Escherichia coli clonal lineages. Infect Immun (1999) 1.86
Mip protein of Legionella pneumophila exhibits peptidyl-prolyl-cis/trans isomerase (PPlase) activity. Mol Microbiol (1992) 1.83
Identification and characterization of a novel genomic island integrated at selC in locus of enterocyte effacement-negative, Shiga toxin-producing Escherichia coli. Infect Immun (2001) 1.82
Binding sites in the rat brain for Escherichia coli S fimbriae associated with neonatal meningitis. J Clin Invest (1988) 1.82
Systematic literature analysis and review of targeted preventive measures to limit healthcare-associated infections by meticillin-resistant Staphylococcus aureus. Euro Surveill (2014) 1.79
tRNA genes and pathogenicity islands: influence on virulence and metabolic properties of uropathogenic Escherichia coli. Mol Microbiol (1995) 1.72
Common molecular mechanisms of symbiosis and pathogenesis. Trends Microbiol (2000) 1.71
Role of Escherichia coli alpha-hemolysin and bacterial adherence in infection: requirement for release of inflammatory mediators from granulocytes and mast cells. Infect Immun (1986) 1.70
Effects of subinhibitory concentrations of antibiotics on alpha-toxin (hla) gene expression of methicillin-sensitive and methicillin-resistant Staphylococcus aureus isolates. Antimicrob Agents Chemother (1998) 1.70
Genetic aspects of Escherichia coli virulence. Microb Pathog (1994) 1.68
Pulsed-field gel electrophoresis of genomic restriction fragments as a tool for the epidemiological analysis of Staphylococcus aureus and coagulase-negative staphylococci. FEMS Microbiol Lett (1992) 1.67
Curli fibers mediate internalization of Escherichia coli by eukaryotic cells. Infect Immun (2001) 1.66
Pathogenicity islands: the tip of the iceberg. Microbes Infect (2001) 1.65
Detection system for Escherichia coli-specific virulence genes: absence of virulence determinants in B and C strains. Appl Environ Microbiol (1997) 1.64
Expression of a chromosomally integrated, single-copy GFP gene in Candida albicans, and its use as a reporter of gene regulation. Mol Gen Genet (1998) 1.61
Analysis of expression of the alpha-toxin gene (hla) of Staphylococcus aureus by using a chromosomally encoded hla::lacZ gene fusion. Infect Immun (1997) 1.61
Bacterial adherence and hemolysin production from Escherichia coli induces histamine and leukotriene release from various cells. Infect Immun (1985) 1.61
Microbial diversity of marine sponges. Prog Mol Subcell Biol (2003) 1.59
PCR for the identification of methicillin-resistant Staphylococcus aureus (MRSA) strains using a single primer pair specific for SCCmec elements and the neighbouring chromosome-borne orfX. Clin Microbiol Infect (2005) 1.59
Isolation and phylogenetic analysis of bacteria with antimicrobial activities from the Mediterranean sponges Aplysina aerophoba and Aplysina cavernicola. FEMS Microbiol Ecol (2001) 1.58
Cloning and sequencing of a Shiga-like toxin II-related gene from Escherichia coli O157:H7 strain 7279. Zentralbl Bakteriol (1992) 1.56
Confirmation of the existence of a third family among peptidyl-prolyl cis/trans isomerases. Amino acid sequence and recombinant production of parvulin. FEBS Lett (1994) 1.56
Resistance to mercury and to cadmium in chromosomally resistant Staphylococcus aureus. Antimicrob Agents Chemother (1986) 1.56
Symbiosis and pathogenesis: evolution of the microbe-host interaction. Naturwissenschaften (2000) 1.56
Adhesion of S-fimbriated Escherichia coli to brain glycolipids mediated by sfaA gene-encoded protein of S-fimbriae. J Biol Chem (1993) 1.55
Evidence for apoptosis of human macrophage-like HL-60 cells by Legionella pneumophila infection. Infect Immun (1996) 1.54
Quinupristin/dalfopristin-resistant enterococci of the satA (vatD) and satG (vatE) genotypes from different ecological origins in Germany. Microb Drug Resist (2000) 1.54
Genetics of Escherichia coli hemolysin. Curr Top Microbiol Immunol (1985) 1.53
Analysis of genes coding for the sialic acid-binding adhesin and two other minor fimbrial subunits of the S-fimbrial adhesin determinant of Escherichia coli. Mol Microbiol (1989) 1.53
[Vancomycin resistant enterococci in Austria]. Wien Klin Wochenschr (1997) 1.51
Whole genome plasticity in pathogenic bacteria. Curr Opin Microbiol (2001) 1.51
Spread of ampicillin/vancomycin-resistant Enterococcus faecium of the epidemic-virulent clonal complex-17 carrying the genes esp and hyl in German hospitals. Eur J Clin Microbiol Infect Dis (2005) 1.51
Host-induced, stage-specific virulence gene activation in Candida albicans during infection. Mol Microbiol (1999) 1.51
Adhesin regulatory genes within large, unstable DNA regions of pathogenic Escherichia coli: cross-talk between different adhesin gene clusters. Mol Microbiol (1994) 1.49
Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center. Antimicrob Agents Chemother (1994) 1.49
Analysis of the genetic determinants coding for the S-fimbrial adhesin (sfa) in different Escherichia coli strains causing meningitis or urinary tract infections. Infect Immun (1986) 1.48
Novel type of fimbriae encoded by the large plasmid of sorbitol-fermenting enterohemorrhagic Escherichia coli O157:H(-). Infect Immun (2001) 1.48
Cloning and genetic characterization of the flagellum subunit gene (flaA) of Legionella pneumophila serogroup 1. Infect Immun (1995) 1.47
Binding of Escherichia coli S fimbriae to human kidney epithelium. Infect Immun (1986) 1.46
Arrangement of the vanA gene cluster in enterococci of different ecological origin. FEMS Microbiol Lett (1997) 1.45
Hemolytic Escherichia coli strains in the human fecal flora as potential urinary pathogens. Zentralbl Bakteriol Mikrobiol Hyg A (1983) 1.43
Characterization of a new enterococcal gene, satG, encoding a putative acetyltransferase conferring resistance to Streptogramin A compounds. Antimicrob Agents Chemother (1999) 1.43
Contribution of cloned virulence factors from uropathogenic Escherichia coli strains to nephropathogenicity in an experimental rat pyelonephritis model. Infect Immun (1986) 1.43
Gene clusters for S fimbrial adhesin (sfa) and F1C fimbriae (foc) of Escherichia coli: comparative aspects of structure and function. J Bacteriol (1988) 1.43
Influence of site specifically altered Mip proteins on intracellular survival of Legionella pneumophila in eukaryotic cells. Infect Immun (1995) 1.42
Superantigen production by Staphylococcus aureus in atopic dermatitis: no more than a coincidence? J Invest Dermatol (1998) 1.41
Influence of RecA on in vivo virulence and Shiga toxin 2 production in Escherichia coli pathogens. Microb Pathog (1999) 1.39
Genome analysis of Legionella ssp. by orthogonal field alternation gel electrophoresis (OFAGE). FEMS Microbiol Lett (1990) 1.39
Obvious lack of association between dynamics of epidemic methicillin-resistant Staphylococcus aureus in central Europe and agr specificity groups. Eur J Clin Microbiol Infect Dis (2003) 1.38
A database system for fragment patterns of genomic DNA of Staphylococcus aureus. Zentralbl Bakteriol (1998) 1.38
Association between quinupristin/dalfopristin resistance in glycopeptide-resistant Enterococcus faecium and the use of additives in animal feed. Eur J Clin Microbiol Infect Dis (1998) 1.37
Typing of Staphylococcus aureus by PCR for DNA sequences flanked by transposon Tn916 target region and ribosomal binding site. J Clin Microbiol (1996) 1.36